{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:10:53Z","timestamp":1772165453029,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T00:00:00Z","timestamp":1549584000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12859-019-2664-1","type":"journal-article","created":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T09:13:19Z","timestamp":1549617199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Predicting clinically promising therapeutic hypotheses using tensor factorization"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9186-459X","authenticated-orcid":false,"given":"Jin","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark R.","family":"Hurle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew R.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,8]]},"reference":[{"issue":"8","key":"2664_CR1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nrd4090","volume":"12","author":"J Arrowsmith","year":"2013","unstructured":"Arrowsmith J, Miller P. Trial watch: phase II and phase III attrition rates 2011-2012. Nat Rev Drug Discov. 2013;12(8):569.","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"2664_CR2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrd4309","volume":"13","author":"D Cook","year":"2014","unstructured":"Cook D, Brown D, Alexander R, March R, Morgan P, Satterthwaite G, Pangalos MN. Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework. Nat Rev Drug Discov. 2014;13(6):419\u201331.","journal-title":"Nat Rev Drug Discov"},{"key":"2664_CR3","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/nrn2494","volume":"9","author":"L Bertram","year":"2008","unstructured":"Bertram L, Tanzi RE. Thirty years of Alzheimer&#39;s disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci. 2008;9:768.","journal-title":"Nat Rev Neurosci"},{"issue":"D1","key":"2664_CR4","doi-asserted-by":"publisher","first-page":"D985","DOI":"10.1093\/nar\/gkw1055","volume":"45","author":"G Koscielny","year":"2016","unstructured":"Koscielny G, An P, Carvalho-Silva D, Cham JA, Fumis L, Gasparyan R, Hasan S, Karamanis N, Maguire M, Papa E. Open targets: a platform for therapeutic target identification and validation. Nucleic Acids Res. 2016;45(D1):D985\u201394.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"2664_CR5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1137\/07070111X","volume":"51","author":"TG Kolda","year":"2009","unstructured":"Kolda TG, Bader BW. Tensor decompositions and applications. SIAM Rev. 2009;51(3):455\u2013500.","journal-title":"SIAM Rev"},{"key":"2664_CR6","doi-asserted-by":"crossref","unstructured":"Koren Y, Bell R, Volinsky C. Matrix factorization techniques for recommender systems. Computer. 2009;42(8).","DOI":"10.1109\/MC.2009.263"},{"issue":"1","key":"2664_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1109\/JPROC.2015.2483592","volume":"104","author":"M Nickel","year":"2016","unstructured":"Nickel M, Murphy K, Tresp V, Gabrilovich E. A review of relational machine learning for knowledge graphs. Proc IEEE. 2016;104(1):11\u201333.","journal-title":"Proc IEEE"},{"issue":"3","key":"2664_CR8","first-page":"511","volume":"18","author":"Y Luo","year":"2017","unstructured":"Luo Y, Wang F, Szolovits P. Tensor factorization toward precision medicine. Brief Bioinform. 2017;18(3):511\u20134.","journal-title":"Brief Bioinform"},{"issue":"8","key":"2664_CR9","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3314","volume":"47","author":"MR Nelson","year":"2015","unstructured":"Nelson MR, Tipney H, Painter JL, Shen J, Nicoletti P, Shen Y, Floratos A, Sham PC, Li MJ, Wang J. The support of human genetic evidence for approved drug indications. Nat Genet. 2015;47(8):856.","journal-title":"Nat Genet"},{"issue":"5","key":"2664_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1006142","volume":"14","author":"AD Rouillard","year":"2018","unstructured":"Rouillard AD, Hurle MR, Agarwal P. Systematic interrogation of diverse Omic data reveals interpretable, robust, and generalizable transcriptomic features of clinically successful therapeutic targets. PLoS Comput Biol. 2018;14(5):e1006142.","journal-title":"PLoS Comput Biol"},{"issue":"5","key":"2664_CR11","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/1471-2105-16-S5-S1","volume":"16","author":"J Sun","year":"2015","unstructured":"Sun J, Zhu K, Zheng WJ, Xu H. A comparative study of disease genes and drug targets in the human protein interactome. BMC Bioinformatics. 2015;16(5):S1.","journal-title":"BMC Bioinformatics"},{"issue":"11","key":"2664_CR12","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.drudis.2016.07.008","volume":"21","author":"F Heinemann","year":"2016","unstructured":"Heinemann F, Huber T, Meisel C, Bundschus M, Leser U. Reflection of successful anticancer drug development processes in the literature. Drug Discov Today. 2016;21(11):1740\u20134.","journal-title":"Drug Discov Today"},{"key":"2664_CR13","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrg3253","volume":"13","author":"Y Moreau","year":"2012","unstructured":"Moreau Y, Tranchevent L-C. Computational tools for prioritizing candidate genes: boosting disease gene discovery. Nat Rev Genet. 2012;13:523.","journal-title":"Nat Rev Genet"},{"issue":"4","key":"2664_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004120","volume":"11","author":"SD Ghiassian","year":"2015","unstructured":"Ghiassian SD, Menche J, Barab\u00e1si A-L. A DIseAse MOdule detection (DIAMOnD) algorithm derived from a systematic analysis of connectivity patterns of disease proteins in the human Interactome. PLoS Comput Biol. 2015;11(4):e1004120.","journal-title":"PLoS Comput Biol"},{"issue":"2","key":"2664_CR15","first-page":"S9","volume":"8","author":"MB Carson","year":"2015","unstructured":"Carson MB, Lu H. Network-based prediction and knowledge mining of disease genes. BMC Med Genet. 2015;8(2):S9.","journal-title":"BMC Med Genet"},{"issue":"5","key":"2664_CR16","doi-asserted-by":"publisher","first-page":"e97079","DOI":"10.1371\/journal.pone.0097079","volume":"9","author":"P Yang","year":"2014","unstructured":"Yang P, Li X, Chua H-N, Kwoh C-K, Ng S-K. Ensemble positive unlabeled learning for disease gene identification. PLoS One. 2014;9(5):e97079.","journal-title":"PLoS One"},{"key":"2664_CR17","doi-asserted-by":"crossref","unstructured":"Chen C, Tong H, Xie L, Ying L, He Q: FASCINATE: fast cross-layer dependency inference on multi-layered networks. In: Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining; San Francisco, California, USA. 2939784: ACM 2016: 765\u2013774.","DOI":"10.1145\/2939672.2939784"},{"key":"2664_CR18","unstructured":"Pharmaprojects Database [\n                    https:\/\/citeline.com\/products\/pharmaprojects\n                    \n                  ]."},{"issue":"2","key":"2664_CR19","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1101\/gr.6888208","volume":"18","author":"L Yao","year":"2008","unstructured":"Yao L, Rzhetsky A. Quantitative systems-level determinants of human genes targeted by successful drugs. Genome Res. 2008;18(2):206\u201313.","journal-title":"Genome Res"},{"issue":"3","key":"2664_CR20","doi-asserted-by":"publisher","first-page":"e0117955","DOI":"10.1371\/journal.pone.0117955","volume":"10","author":"SC Bull","year":"2015","unstructured":"Bull SC, Doig AJ. Properties of protein drug target classes. PLoS One. 2015;10(3):e0117955.","journal-title":"PLoS One"},{"issue":"12","key":"2664_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004597","volume":"11","author":"C Mitsopoulos","year":"2015","unstructured":"Mitsopoulos C, Schierz AC, Workman P, Al-Lazikani B. Distinctive behaviors of Druggable proteins in cellular networks. PLoS Comput Biol. 2015;11(12):e1004597.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"2664_CR22","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/1471-2105-13-294","volume":"13","author":"A Mora","year":"2012","unstructured":"Mora A, Donaldson IM. Effects of protein interaction data integration, representation and reliability on the use of network properties for drug target prediction. BMC Bioinformatics. 2012;13(1):294.","journal-title":"BMC Bioinformatics"},{"key":"2664_CR23","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/nrd.2016.184","volume":"15","author":"RK Harrison","year":"2016","unstructured":"Harrison RK. Phase II and phase III failures: 2013\u20132015. Nat Rev Drug Discov. 2016;15:817.","journal-title":"Nat Rev Drug Discov"},{"key":"2664_CR24","doi-asserted-by":"crossref","unstructured":"Ma H, Yang H, Lyu MR, King I: Sorec: social recommendation using probabilistic matrix factorization. In: Proceedings of the 17th ACM conference on information and knowledge management: 2008. ACM: 931\u2013940.","DOI":"10.1145\/1458082.1458205"},{"key":"2664_CR25","first-page":"1257","volume-title":"Advances in neural information processing systems","author":"A Mnih","year":"2008","unstructured":"Mnih A, Salakhutdinov RR. Probabilistic matrix factorization. In: Advances in neural information processing systems; 2008. p. 1257\u201364."},{"key":"2664_CR26","doi-asserted-by":"crossref","unstructured":"Salakhutdinov R, Mnih A: Bayesian probabilistic matrix factorization using Markov chain Monte Carlo. In: Proceedings of the 25th international conference on machine learning: 2008. ACM: 880\u2013887.","DOI":"10.1145\/1390156.1390267"},{"key":"2664_CR27","unstructured":"Simm J, Arany A, Zakeri P, Haber T, Wegner JK, Chupakhin V, Ceulemans H, Moreau Y: Macau: scalable bayesian multi-relational factorization with side information using MCMC. arXiv preprint arXiv:150904610 2015."},{"key":"2664_CR28","unstructured":"Julia implementation of Bayesian tensor factorization algorithm [\n                    https:\/\/github.com\/jaak-s\/BayesianDataFusion.jl\n                    \n                  ]."},{"key":"2664_CR29","volume-title":"Bayesian Data Analysis","author":"A Gelman","year":"2014","unstructured":"Gelman A, Carlin JB, Stern HS, Dunson DB, Vehtari A, Rubin DB. Bayesian Data Analysis, vol. 2. Boca Raton, FL: CRC press; 2014."},{"issue":"D1","key":"2664_CR30","doi-asserted-by":"publisher","first-page":"D1083","DOI":"10.1093\/nar\/gkt1031","volume":"42","author":"AP Bento","year":"2014","unstructured":"Bento AP, Gaulton A, Hersey A, Bellis LJ, Chambers J, Davies M, Kr\u00fcger FA, Light Y, Mak L, McGlinchey S. The ChEMBL bioactivity database: an update. Nucleic Acids Res. 2014;42(D1):D1083\u201390.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2664_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1.","journal-title":"J Stat Softw"},{"key":"2664_CR32","doi-asserted-by":"crossref","unstructured":"Friedman JH. Greedy function approximation: a gradient boosting machine. Ann Stat. 2001:1189\u2013232.","DOI":"10.1214\/aos\/1013203451"},{"key":"2664_CR33","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C: Xgboost: A scalable tree boosting system. In: Proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining: 2016. ACM: 785\u2013794.","DOI":"10.1145\/2939672.2939785"},{"key":"2664_CR34","unstructured":"Mazumder R, Hastie T, Tibshirani R. Spectral regularization algorithms for learning large incomplete matrices. J Mach Learn Res. 2010;(11):2287\u2013322."},{"issue":"Nov","key":"2664_CR35","first-page":"2579","volume":"9","author":"HG Maaten Lvd","year":"2008","unstructured":"Maaten Lvd HG. Visualizing data using t-SNE. J Mach Learn Res. 2008;9(Nov):2579\u2013605.","journal-title":"J Mach Learn Res"},{"issue":"6224","key":"2664_CR36","doi-asserted-by":"publisher","first-page":"1257601","DOI":"10.1126\/science.1257601","volume":"347","author":"J Menche","year":"2015","unstructured":"Menche J, Sharma A, Kitsak M, Ghiassian SD, Vidal M, Loscalzo J, Barab\u00e1si A-L. Uncovering disease-disease relationships through the incomplete interactome. Science. 2015;347(6224):1257601.","journal-title":"Science"},{"key":"2664_CR37","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nbt.2786","volume":"32","author":"M Hay","year":"2014","unstructured":"Hay M, Thomas DW, Craighead JL, Economides C, Rosenthal J. Clinical development success rates for investigational drugs. Nat Biotechnol. 2014;32:40.","journal-title":"Nat Biotechnol"},{"issue":"9","key":"2664_CR38","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1002\/art.39700","volume":"68","author":"PJ Mease","year":"2016","unstructured":"Mease PJ, Gottlieb AB, Berman A, Drescher E, Xing J, Wong R, Banerjee S. The efficacy and safety of clazakizumab, an anti\u2013interleukin-6 monoclonal antibody, in a phase IIb study of adults with active psoriatic arthritis. Arthritis Rheumatol. 2016;68(9):2163\u201373.","journal-title":"Arthritis Rheumatol"},{"key":"2664_CR39","unstructured":"Uniprot entry of IL6 [\n                    http:\/\/www.uniprot.org\/uniprot\/P05231\n                    \n                  ]."},{"issue":"7","key":"2664_CR40","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s10067-016-3301-2","volume":"35","author":"N Cubino","year":"2016","unstructured":"Cubino N, Montilla C, Usategui-Mart\u00edn R, Cieza-Borrela C, Carranco T, Calero-Paniagua I, Quesada A, Ca\u00f1ete J, Queiro R, S\u00e1nchez M. Association of IL1\u0392 (\u2212511 a\/C) and IL6 (\u2212174 G> C) polymorphisms with higher disease activity and clinical pattern of psoriatic arthritis. Clin Rheumatol. 2016;35(7):1789\u201394.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"2664_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3109\/14397595.2016.1174328","volume":"27","author":"S Muramatsu","year":"2017","unstructured":"Muramatsu S, Kubo R, Nishida E, Morita A. Serum interleukin-6 levels in response to biologic treatment in patients with psoriasis. Mod Rheumatol. 2017;27(1):137\u201341.","journal-title":"Mod Rheumatol"},{"issue":"7","key":"2664_CR42","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1161\/01.ATV.0000022847.38083.B6","volume":"22","author":"S Wassmann","year":"2002","unstructured":"Wassmann S, Hilgers S, Laufs U, B\u00f6hm M, Nickenig G. Angiotensin II type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction. Arterioscler Thromb Vasc Biol. 2002;22(7):1208\u201312.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"2664_CR43","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1161\/01.HYP.0000154085.27868.93","volume":"45","author":"T Petnehazy","year":"2005","unstructured":"Petnehazy T, Stokes KY, Russell JM, Granger DN. Angiotensin II type-1 receptor antagonism attenuates the inflammatory and thrombogenic responses to hypercholesterolemia in venules. Hypertension. 2005;45(2):209\u201315.","journal-title":"Hypertension"},{"issue":"1","key":"2664_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0009-8981(00)00402-2","volume":"304","author":"T Morisawa","year":"2001","unstructured":"Morisawa T, Kishimoto Y, Kitano M, Kawasaki H, Hasegawa J. Influence of angiotensin II type 1 receptor polymorphism on hypertension in patients with hypercholesterolemia. Clin Chim Acta. 2001;304(1):91\u20137.","journal-title":"Clin Chim Acta"},{"key":"2664_CR45","doi-asserted-by":"crossref","unstructured":"Costa PR, Acencio ML, Lemke N: A machine learning approach for genome-wide prediction of morbid and druggable human genes based on systems-level data. In: BMC Genomics: 2010. BioMed Central: S9.","DOI":"10.1186\/1471-2164-11-S5-S9"},{"issue":"20","key":"2664_CR46","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1093\/bioinformatics\/bts504","volume":"28","author":"P Yang","year":"2012","unstructured":"Yang P, Li X-L, Mei J-P, Kwoh C-K, Ng S-K. Positive-unlabeled learning for disease gene identification. Bioinformatics. 2012;28(20):2640\u20137.","journal-title":"Bioinformatics"},{"issue":"4","key":"2664_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060618","volume":"8","author":"D Emig","year":"2013","unstructured":"Emig D, Ivliev A, Pustovalova O, Lancashire L, Bureeva S, Nikolsky Y, Bessarabova M. Drug target prediction and repositioning using an integrated network-based approach. PLoS One. 2013;8(4):e60618.","journal-title":"PLoS One"},{"key":"2664_CR48","doi-asserted-by":"crossref","unstructured":"Barab\u00e1si A-L, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet. 2010, 12:56.","DOI":"10.1038\/nrg2918"},{"key":"2664_CR49","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale J, Thomas J, Salvatore M, Phillips R, Lo E, Shad S, Hasz R, Walters G, Garcia F, Young N, et al. The genotype-tissue expression (GTEx) project. Nat Genet. 2013;45:580.","journal-title":"Nat Genet"},{"key":"2664_CR50","doi-asserted-by":"crossref","unstructured":"Uhl\u00e9n M, Fagerberg L, Hallstr\u00f6m BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson \u00c5, Kampf C, Sj\u00f6stedt E, Asplund A, et al. Tissue-based map of the human proteome. Science. 2015;347(6220).","DOI":"10.1126\/science.1260419"},{"key":"2664_CR51","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nature19057","volume":"536","author":"M Lek","year":"2016","unstructured":"Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O\u2019Donnell-Luria AH, Ware JS, Hill AJ, Cummings BB, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285.","journal-title":"Nature"},{"issue":"8","key":"2664_CR52","doi-asserted-by":"publisher","first-page":"e1003709","DOI":"10.1371\/journal.pgen.1003709","volume":"9","author":"S Petrovski","year":"2013","unstructured":"Petrovski S, Wang Q, Heinzen EL, Allen AS, Goldstein DB. Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet. 2013;9(8):e1003709.","journal-title":"PLoS Genet"},{"issue":"W1","key":"2664_CR53","doi-asserted-by":"publisher","first-page":"W589","DOI":"10.1093\/nar\/gkv350","volume":"43","author":"D Smedley","year":"2015","unstructured":"Smedley D, Haider S, Durinck S, Pandini L, Provero P, Allen J, Arnaiz O, Awedh MH, Baldock R, Barbiera G, et al. The BioMart community portal: an innovative alternative to large, centralized data repositories. Nucleic Acids Res. 2015;43(W1):W589\u201398.","journal-title":"Nucleic Acids Res"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-019-2664-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-019-2664-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-019-2664-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T19:09:18Z","timestamp":1581102558000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-019-2664-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,8]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2664"],"URL":"https:\/\/doi.org\/10.1186\/s12859-019-2664-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/272740","asserted-by":"object"}]},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,8]]},"assertion":[{"value":"26 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JY, MH, MN, and PA are full-time employees of GSK.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"69"}}